UnitedHealth price target lowered to $580 from $660 at Truist

Truist lowered the firm’s price target on UnitedHealth (UNH) to $580 from $660 but keeps a Buy rating on the shares after its Q1 earnings miss and guidance cut. The firm remains bullish on UnitedHealth, noting that while the FY25 guidance revision tied to unanticipated member profile changes at Optum Health and heightened MA care activity was disappointing, it also expects steps to address the profile changes and believes that Medicare Advantage trend emergence early in the year, coupled with the better than expected Final rate, should aid flexibility into 2026, the analyst tells investors in a research note.